Bionic Sight Llc

This study tests a gene therapy called BS01 for people with retinitis pigmentosa, an inherited eye disease that causes gradual vision loss. The therapy delivers a light-sensitive protein to cells in the retina, aiming to help them detect light again. Twenty participants with seve…

This study tests a new gene therapy called BS01 for people with geographic atrophy, a severe form of dry age-related macular degeneration that causes blind spots. The treatment uses a harmless virus to deliver a light-sensitive protein to the eye, aiming to restore or preserve vi…